| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NXSTAGE MED INC COM | 11,800 | 186,000 | 0.01% | ||
| 2 | FLUIDIGM CORP DEL COM | 24,583 | 199,000 | 0.02% | ||
| 3 | CERNER CORP | 3,563 | 214,000 | 0.02% | ||
| 4 | JAZZ PHARMACEUTICALS PLC | 1,769 | 235,000 | 0.02% | ||
| 5 | ADURO BIOTECH INC | 16,056 | 311,000 | 0.02% | ||
| 6 | Sierra Oncology, Inc. | 18,391 | 377,000 | 0.03% | ||
| 7 | MARKET VECTORS PHARMACEUTICAL | 6,500 | 409,000 | 0.03% | ||
| 8 | SPDR SER TR | 9,250 | 576,000 | 0.04% | ||
| 9 | GENOCEA BIOSCIENCES INC | 91,644 | 628,000 | 0.05% | ||
| 10 | NEVRO CORP COM | 25,000 | 1,160,000 | 0.09% | ||
| 11 | IRONWOOD PHARMACEUTICALS INC | 190,789 | 1,988,000 | 0.15% | ||
| 12 | ELEVEN BIOTHERAPEUTICS INC | 848,351 | 2,045,000 | 0.15% | ||
| 13 | PRESS GANEY HLDGS INC | 84,966 | 2,514,000 | 0.19% | ||
| 14 | CHEMOCENTRYX INC | 500,615 | 3,029,000 | 0.23% | ||
| 15 | CASTLIGHT HEALTH INC COM CL B | 734,397 | 3,084,000 | 0.23% | ||
| 16 | ARRAY BIOPHARMA INC 3 06/01/2020 | 4,000,000 | 3,942,000 | 0.30% | PRN | |
| 17 | INVITAE CORP | 660,129 | 4,766,000 | 0.36% | ||
| 18 | INFINITY PHARMACEUTICALS INC | 590,100 | 4,986,000 | 0.38% | ||
| 19 | DURECT CORP | 2,613,316 | 5,096,000 | 0.39% | ||
| 20 | REGENXBIO INC COM | 277,000 | 6,102,000 | 0.46% | ||
| 21 | AVALANCHE BIOTECHNOLOGIES IN | 748,420 | 6,167,000 | 0.47% | ||
| 22 | AQUINOX PHARMACEUTICALS INC | 514,300 | 7,236,000 | 0.55% | ||
| 23 | CERUS CORP | 1,603,427 | 7,280,000 | 0.55% | ||
| 24 | TRIVASCULAR TECHNOLOGIES INC | 1,463,983 | 7,320,000 | 0.55% | ||
| 25 | BLUEPRINT MEDICINES CORP COM | 367,485 | 7,842,000 | 0.59% | ||
| 26 | ProQR Therapeutics NV | 660,816 | 9,628,000 | 0.73% | ||
| 27 | ONCOTHYREON INC COM N/C EFF 6/ | 3,614,990 | 9,905,000 | 0.75% | ||
| 28 | TRINET GROUP INC COM | 639,186 | 10,738,000 | 0.81% | ||
| 29 | HEALTH NET INC | 179,229 | 10,793,000 | 0.82% | ||
| 30 | FATE THERAPEUTICS INC | 2,074,836 | 11,059,000 | 0.84% | ||
| 31 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 262,892 | 11,084,000 | 0.84% | ||
| 32 | CONFORMIS INCORPORATED | 688,845 | 12,441,000 | 0.94% | ||
| 33 | Oxford Immunotec Global PLC | 1,028,132 | 13,880,000 | 1.05% | ||
| 34 | MODEL N INCORPORATED | 1,443,278 | 14,447,000 | 1.09% | ||
| 35 | INSMED INC | 947,966 | 17,604,000 | 1.33% | ||
| 36 | DYNAVAX TECHNOLOGIES CORP | 724,348 | 17,775,000 | 1.35% | ||
| 37 | DBV TECHNOLOGIES S A | 532,818 | 18,963,000 | 1.44% | ||
| 38 | CELLDEX THERAPEUTICS INC NEW | 1,954,019 | 20,595,000 | 1.56% | ||
| 39 | NANOSTRING TECHNOLOGIES INC | 1,385,641 | 22,170,000 | 1.68% | ||
| 40 | NEURODERM LTD | 1,462,699 | 30,234,000 | 2.29% | ||
| 41 | PORTOLA PHARMACEUTICALS INC | 769,641 | 32,802,000 | 2.49% | ||
| 42 | Atara Biotherapeutics Inc | 1,049,782 | 33,005,000 | 2.50% | ||
| 43 | ZS PHARMA INC | 514,107 | 33,756,000 | 2.56% | ||
| 44 | BIOMARIN PHARMACEUTICAL INC | 368,775 | 38,839,000 | 2.94% | ||
| 45 | CENTENE CORP DEL | 747,460 | 40,535,000 | 3.07% | ||
| 46 | CHIMERIX INC | 1,067,978 | 40,797,000 | 3.09% | ||
| 47 | WELLCARE HEALTH PLANS INC | 514,273 | 44,320,000 | 3.36% | ||
| 48 | SAGE THERAPEUTICS INC | 1,142,864 | 48,366,000 | 3.66% | ||
| 49 | RITE AID CORP | 8,071,405 | 48,993,000 | 3.71% | ||
| 50 | PENUMBRA INC COM | 1,562,587 | 51,010,000 | 3.86% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001425738-15-000021, filed 2015.11.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
